证券日报网2月26日讯，华伍股份（300095）在接受调研者提问时表示，公司工业制动器产品的海外业 务收入基数较低，发展较慢。公司今年将海外港口市场、风电市场集中统筹海外市场团队管理，将通过 优化专业团队、调配内部资源，加快瑞士子公司建设，提升海外子品牌的影响，加强海外业务收入。 ...

声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 本文源自：市场资讯 作者：公告君 有投资者在互动平台向赛科希德提问："海外收入下半年与上半年有哪些突破，占比提升多少。" 针对上述提问，赛科希德回应称："尊敬的投资者您好，近年来公司高度重视海外业务发展，业务范围 已经拓展到俄罗斯、中东、南美等国家和地区。海外业务在公司整体业务中占比不高，目前处于发展和 增长的阶段。具体情况请关注公司后续披露的2025年年度报告，感谢您对公司业务的关注。" ...

证券日报网讯1月20日，广联达（002410）在互动平台回答投资者提问时表示，海外业务是公司比较确 定的发展方向，现阶段的重点区域包括亚洲市场和其他地区。 ...

Group 1 - The core viewpoint of the article highlights that Hailiang Co., Ltd. has established itself as the first Chinese copper foil factory operating overseas, specifically in Indonesia, and is accelerating its international business development through partnerships with major global clients [2] - Hailiang has signed supply agreements with five of the top ten global power battery customers and two of the top three 3C digital customers, with these agreements set to commence in 2026, detailing product specifications, quantities, and financial terms [2] - The company anticipates a promising outlook for its operations in Indonesia, which is expected to enhance Hailiang's competitive edge in the international copper foil market [2]

证券日报网12月11日讯亚普股份（603013）在12月9日回答调研者提问时表示，公司海外业务近几年逐 渐向好的原因主要有三个方面：一是公司海外工厂通过智能化升级改造，提升了生产效率，降低了人工 成本；二是强化了总部对海外子公司的管理提升，提高了海外工厂的生产和运营管理效率；三是海外汽 车市场相较国内市场纯电动汽车市场占比较低，燃油汽车及混动汽车仍占据市场绝对主流，为公司燃油 系统业务的发展提供了相对良好的环境。 ...

Core Points - China Metallurgical Group Corporation (China MCC) experienced a nearly 3% decline in stock price, trading at HKD 2.27 with a transaction volume of HKD 37.68 million [1] - As of November 14, China MCC announced that its new contract value for January to October 2025 was RMB 845.07 billion, a decrease of 11.8% compared to the same period last year [1] - The company reported that its new overseas contract value reached RMB 71.16 billion, reflecting a growth of 7.3% year-on-year [1] - Everbright Securities has downgraded the company's net profit forecasts for 2025 and 2026 to RMB 4.79 billion and RMB 4.99 billion, representing reductions of 30% and 26% respectively [1] - The new net profit forecast for 2027 is set at RMB 5.23 billion [1] - Despite the challenges faced in the steel, construction, and real estate sectors, Everbright Securities remains optimistic about the company's overseas and resource business development, maintaining a "buy" rating for both A-shares and H-shares [1]

Investment Rating - The investment rating for the company is "Outperform the Market" [6][4]. Core Views - The company achieved a revenue of 25.033 billion yuan in the first three quarters of 2025, representing a year-on-year increase of 1.27%. The net profit attributable to shareholders was 2.004 billion yuan, up 76.0% year-on-year, with a basic earnings per share (EPS) of 0.97 yuan [9][4]. - The growth in revenue and profit is primarily attributed to the expansion of overseas business and the consolidation of the Nigerian acquisition, while domestic cement prices and volumes remain under pressure [4][9]. - The company has made significant progress in its internationalization strategy, with non-cement business contributing 43% to revenue and 44% to EBITDA as of mid-2025 [4][25]. Financial Performance - The gross margin improved to 29.5%, an increase of 5.47 percentage points year-on-year, with quarterly gross margins showing a slight decline in Q3 compared to Q2 [3][12]. - Operating cash flow for the first nine months was 3.227 billion yuan, a decrease of 4.6% year-on-year, while the debt-to-asset ratio was 53.22%, slightly up from the previous quarter but still manageable [12][3]. - The company expects EPS for 2025-2027 to be 1.43, 1.77, and 1.92 yuan per share, with corresponding price-to-earnings (PE) ratios of 15.6, 12.6, and 11.6 [4][5]. Overseas Expansion - The company has established operations in 14 countries, including Tajikistan and Kyrgyzstan, and completed the equity transfer for the Nigerian acquisition, which has a cement production capacity of approximately 10.6 million tons per year [4][25]. - The overseas grinding capacity has surpassed 35 million tons per year, with ongoing projects in Mozambique expected to further enhance production capabilities [25][4]. Future Outlook - The company maintains its "Outperform the Market" rating, focusing on the continued growth of overseas operations and the potential recovery of domestic cement prices due to supply-side optimization [4][5]. - The financial forecasts indicate a stable growth trajectory, with expected revenue growth rates of 4.3% in 2025 and 11.2% in 2026 [5][4].

Core Viewpoint - The company, Haitai Biotech (300683.SZ), announced plans to initiate the preparatory work for issuing H-shares and listing on the Hong Kong Stock Exchange by October 22, 2025, aiming to enhance its global strategy and accelerate overseas business development [1] Group 1: Strategic Intent - The company aims to deepen its global strategy and enhance its international brand image through the issuance of H-shares [1] - The move is intended to create a diversified capital operation platform [1] Group 2: Implementation Details - The company plans to discuss specific implementation steps with intermediary institutions, although details are not yet finalized [1] - The issuance and listing of H-shares will require approval from the board of directors, shareholders, and relevant government and regulatory agencies, indicating significant uncertainty in the process [1]

Core Viewpoint - The company, Sinovac Biotech Ltd. (科兴制药), aims to enhance its strategic layout of "innovation + internationalization" by accelerating overseas business development and improving its overall competitiveness and international brand image through the issuance of H-shares and listing on the Hong Kong Stock Exchange [1] Group 1 - The company plans to issue H-shares to optimize its capital structure [1] - The move is intended to leverage the advantages of international capital markets for diversified financing channels [1] - The initiative is part of the company's strategy to deepen its presence in the global market [1]

Core Insights - The chemical industry in China is experiencing mixed performance, with overall revenue and net profit growth of 2.35% and 3.92% respectively in the first half of 2025 compared to the previous year [1] - A total of 237 out of 436 listed chemical companies reported year-on-year net profit growth, with 124 companies exceeding 30% growth [4] Industry Performance - Non-metal materials, plastics, agricultural chemicals, and chemical products showed significant net profit growth, with increases of 21.1%, 19.77%, 14.66%, and 3.08% respectively [1] - Conversely, chemical fibers, rubber, and chemical raw materials faced declines in net profit, with decreases of -18.5%, -15.59%, and -2.73% respectively [1] - In the plastics sector, synthetic resins and modified plastics had notable net profit increases of 34.17% and 23.08% [2] - The agricultural chemicals sector saw exceptional growth in pesticides, potassium fertilizers, and compound fertilizers, with net profit increases of 120.54%, 40.1%, and 13.25% respectively [2] - The chemical products sector also performed well, particularly in fluorine chemicals and food additives, with net profit growth of 89.53% and 37.98% [2] - The chemical raw materials sector had strong performers like other chemical raw materials and chlor-alkali, with net profit increases of 36.18% and 26.75% [3] Company Highlights - Notable companies such as Xinda Co., Su Li Co., and Lianhua Technology reported net profit growth exceeding 1000% in the first half of 2025 [4] - New and Cheng achieved a revenue of 11.1 billion yuan, a 12.76% increase, and a net profit of 3.6 billion yuan, a 63.46% increase [5] - Juhua Co. reported total revenue of 13.33 billion yuan, a 10.36% increase, and a net profit of 2.05 billion yuan, a 146.97% increase [5] Institutional Research Focus - Institutional research is concentrated on identifying growth drivers for the second half of the year, R&D investment directions, sources of performance growth, overseas business development, and market value management [6][7] - Companies like New and Cheng are focusing on nutrition, flavoring, and new materials to enhance revenue [7] - Huami New Materials reported a 16.20% increase in R&D investment, focusing on automotive and aerospace sectors [7] - Companies are actively expanding overseas markets, with efforts in rail transit and rubber tape projects in Europe [8]